Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a232e4f3bc49d434

Jump to content

Crebinostat

From Wikipedia, the free encyclopedia
Crebinostat
Clinical data
Drug classHistone deacetylase inhibitor; Cognitive enhancer
ATC code
  • None
Identifiers
  • N'-hydroxy-N-[(E)-(4-phenylphenyl)methylideneamino]heptanediamide
PubChem CID
ChemSpider
ChEBI
ChEMBL
Chemical and physical data
FormulaC20H23N3O3
Molar mass353.422 g·mol−1
3D model (JSmol)
  • C1=CC=C(C=C1)C2=CC=C(C=C2)/C=N/NC(=O)CCCCCC(=O)NO
  • InChI=1S/C20H23N3O3/c24-19(9-5-2-6-10-20(25)23-26)22-21-15-16-11-13-18(14-12-16)17-7-3-1-4-8-17/h1,3-4,7-8,11-15,26H,2,5-6,9-10H2,(H,22,24)(H,23,25)/b21-15+
  • Key:AEIVDBATQVVQFS-RCCKNPSSSA-N

Crebinostat is a histone deacetylase (HDAC) inhibitor and possible cognitive enhancer.[1][2][3]

It specifically inhibits the class I HDAC1, HDAC2, and HDAC3, the class IIb HDAC6, and weakly the class I HDAC8, with no significant inhibition of the class IIa HDAC4, HDAC5, HDAC7, or HDAC9.[1] The drug has been found to robustly activate CREB-mediated transcription and to upregulate brain-derived neurotrophic factor (BDNF) expression and increase synaptogenesis.[1] It has been found to enhance memory in rodents.[1][3] The pharmacokinetics of crebinostat have been studied in rodents.[1]

Crebinostat was first described in the scientific literature by 2013.[1] It was identified via screening of a library of over 1,200 compounds designed to target HDACs.[1] There is interest in crebinostat as a potential novel cognitive enhancer in humans.[1][2] Subsequent to the development of crebinostat, an analogue known as neurinostat with improved properties was discovered and described.[2]

See also

[edit]

References

[edit]
  1. 1 2 3 4 5 6 7 8 Fass DM, Reis SA, Ghosh B, Hennig KM, Joseph NF, Zhao WN, Nieland TJ, Guan JS, Kuhnle CE, Tang W, Barker DD, Mazitschek R, Schreiber SL, Tsai LH, Haggarty SJ (January 2013). "Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity". Neuropharmacology. 64: 81–96. doi:10.1016/j.neuropharm.2012.06.043. PMC 3447535. PMID 22771460.
  2. 1 2 3 Ghosh B, Zhao WN, Reis SA, Patnaik D, Fass DM, Tsai LH, Mazitschek R, Haggarty SJ (February 2016). "Dissecting structure-activity-relationships of crebinostat: Brain penetrant HDAC inhibitors for neuroepigenetic regulation". Bioorg Med Chem Lett. 26 (4): 1265–1271. doi:10.1016/j.bmcl.2016.01.022. PMC 4753070. PMID 26804233.
  3. 1 2 Dama D, Sharma SK (May 2024). "Crebinostat facilitates memory formation". Biochem Biophys Res Commun. 710: 149872. doi:10.1016/j.bbrc.2024.149872. PMID 38593621.{{cite journal}}: CS1 maint: article number as page number (link)